Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Synagis
Synagis is the brand name for palivizumab. [1]
Palivizumab is a monoclonal antibody used to help prevent respiratory syncytial virus (RSV) infection in certain high-risk children. [1]
The information provided here identifies Synagis’s generic name as palivizumab. If you’re looking for whether an FDA-approved generic (or biosimilar) version exists and where, you may need to check current availability and approval status by regulator and market. [1]
1
Other Questions About Synagis :